NCT07698132

Brief Summary

The HALO trial is designed as a four-armed, assessor-blinded, fidelity-monitored randomized clinical trial. The goal of this randomized controlled study is to investigate the effectiveness of four different psychotherapy programs and to determine which one is most effective in reducing the number of binge-eating episodes in people with the eating disorder Binge Eating Disorder (BED), by directly comparing three intensities of Cognitive Behavioral Therapy-Enhanced against a manualized treatment as usual. Participants will be asked to complete a 21-weeks randomized intervention and participate in follow up assesments.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
256

participants targeted

Target at P75+ for not_applicable

Timeline
77mo left

Started Jun 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Jun 2024Dec 2032

Study Start

First participant enrolled

June 10, 2024

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

July 7, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 13, 2026

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2032

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2032

Last Updated

July 13, 2026

Status Verified

July 1, 2026

Enrollment Period

8.5 years

First QC Date

July 7, 2026

Last Update Submit

July 7, 2026

Conditions

Keywords

Binge Eating DisorderEating DisordersCognitive Behavioral TherapyPsychotherapyRandomized Controlled TrialEvidence-based Psychiatry

Outcome Measures

Primary Outcomes (1)

  • Eating Disorder Examination Questionnaire (EDE-Q)

    The primary outcome will be binge eating frequency which is measured by the EDE-Q. To meet the abstinence criteria in the current study there should be no binge eating episodes associated with the sense of loss of control in the past month. The EDE-Q is a 28-item questionnaire designed to assess severity of features associated with eating disorders. The EDE- Q has demonstrated good internal consistency, convergent and construct validity and test-retest reliability.

    Baseline, at end of treatment at 20/21 weeks, at 6 months follow up, at 1 year follow up, at 2 year follow up, at 3 year follow up, at 4 year follow up, at 5 year follow up.

Secondary Outcomes (5)

  • Eating Disorder Examination Interview (EDE-17)

    At baseline and 4-8 weeks after end of therapy

  • World Health Organization Well-Being Index (WHO-5)

    Baseline, at end of treatment at 20/21 weeks, at 6 months follow up, at 1 year follow up, at 2 year follow up, at 3 year follow up, at 4 year follow up, at 5 year follow up.

  • The Work and Social Adjustment Scale (WSAS)

    Baseline, at end of treatment at 20/21 weeks, at 6 months follow up, at 1 year follow up, at 2 year follow up, at 3 year follow up, at 4 year follow up, at 5 year follow up.

  • State-Trait Anxiety Inventory (STAI)

    Baseline, at end of treatment at 20/21 weeks and at 6 months follow up.

  • The Beck Depression Inventory (BDI-II)

    Baseline, at end of treatment at 20/21 weeks and at 6 months follow up.

Study Arms (4)

Cognitive Behavioural Therapy Enhanced - Individual

ACTIVE COMPARATOR
Behavioral: Cognitive Behavioral Therapy Enhanced - Individual

Cognitive Behavioural Therapy Enhanced - Group

ACTIVE COMPARATOR
Behavioral: Cognitive Behavioral Therapy Enhanced - Group

Cognitive Behavioural Therapy Enhanced - Guided Self Help

ACTIVE COMPARATOR
Behavioral: Cognitive Behavioral Therapy - Guided Self Help

Manualized Treatment As Usual

ACTIVE COMPARATOR
Behavioral: Systemic Narrative Therapy - Group

Interventions

Cognitive Behavioral Therapy Enhanced (CBT-E) (individual) is delivered in 20, 50-minute sessions over 20 weeks, following four stages. Stage 1 (sessions 0-7) consists of twice-weekly sessions to establish treatment momentum, self-monitoring, and regular eating. Stages 2 (sessions 8-9) and 3 (sessions 10-17) are delivered weekly. Stage 2 focuses on reviewing progress and planning the remainder of treatment. In Stage 3, the therapist tailors treatment to the individual by selecting one or more modules addressing (1) body image, (2) dietary restraint, and (3) events, moods, and eating, while also covering setbacks and unhelpful mindsets. Stage 4 (sessions 18-20) is delivered fortnightly and focuses on ending therapy, maintaining progress, and relapse prevention. Each session follows a consistent structure, beginning with in-session weighing, followed by a review of self-monitoring records and homework, agenda setting, and work on the session's goals.

Cognitive Behavioural Therapy Enhanced - Individual

Cognitive Behavioral Therapy Enhanced (group) is group therapy delivered in groups with eight participants and two therapists. The groups are closed, meaning the same eight participants start and finish at the same time. The course consists of one individual session before the group starts, and thereafter 20 weeks of weekly two-hour group sessions. A group manual has been developed by our research group (available upon request), based on 'Cognitive Behavior Therapy Enhanced for Eating Disorders' and 'Overcoming Binge Eating' .

Cognitive Behavioural Therapy Enhanced - Group

Cognitive Behavioral Therapy (guided self-help) is a therapist-assisted online treatment based on the principles of CBT-E (see above). Participants access the program from home and receive concurrent brief individual support sessions aimed at developing treatment goals, monitoring progress, and encouraging adherence to the program. The treatment begins with a one-hour face-to-face session with a therapist in week 1, followed by eight brief telephone sessions over the course of treatment: weekly calls during the first four weeks (weeks 2, 3, 4), then fortnightly calls for four weeks (weeks 6 and 8), and finally calls every third week until the end of therapy (weeks 11, 14, and 17). The treatment concludes with a one-hour face-to-face session with a therapist in week 20 focused on reviewing progress, maintaining gains, and relapse prevention. The online program was developed by Digital Psychiatry and adapted by our research group to adhere more closely to CBT-E principles.

Cognitive Behavioural Therapy Enhanced - Guided Self Help

Systemic Narrative Therapy (group) is the standard outpatient treatment for eating disorders within Mental Health Services of the Capital Region of Denmark. The intervention integrates principles of systemic and narrative psychotherapy and is delivered in groups of approximately eight participants by two therapists. Treatment consists of weekly 3.5-hour sessions over approximately 21 weeks, including individual weighing, a shared meal, and structured group psychotherapy. Therapeutic techniques include reflecting teams, collaborative exploration, and externalizing conversations to help participants separate themselves from the eating disorder and develop alternative narratives. The intervention also includes routine weight monitoring and dietary self-monitoring as part of standard clinical care.

Manualized Treatment As Usual

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Binge Eating Disorder according to DSM-5 criteria
  • years of age
  • Fluent Danish speaker

You may not qualify if:

  • Concurrent psychotherapeutic treatment
  • Use of weight loss medications within the last month (i.e., GLP-1 receptor antagonists)
  • Suicidal ideation or suicidality
  • Psychosis or psychotic disorders
  • Mania or bipolar disorder
  • Drug misuse disorder
  • Alcohol misuse disorder
  • Cluster B personality disorders in the severe range (diagnosed)
  • Dosage of Antidepressants, Antipsychotics and Stimulants must be stable for at least 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mental Health Centre Ballerup

Ballerup Municipality, Capital Region, 2750, Denmark

RECRUITING

MeSH Terms

Conditions

Binge-Eating DisorderBulimiaFeeding and Eating Disorders

Condition Hierarchy (Ancestors)

Mental DisordersHyperphagiaSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Research, Professor of Psychiatry

Study Record Dates

First Submitted

July 7, 2026

First Posted

July 13, 2026

Study Start

June 10, 2024

Primary Completion (Estimated)

December 1, 2032

Study Completion (Estimated)

December 1, 2032

Last Updated

July 13, 2026

Record last verified: 2026-07

Locations